SKL-DES

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameSKL-DES
Drug Alias Nameisoxazole derivative drug-eluting stent (SK Life Scence)SKL-DESSKL-2020
ClassificationSmall molecules
Mechanisms of ActionCatenin beta 1 modulatorsWingless type MMTV integration site family protein modulators
TargetsWingless type MMTV integration site family proteinCatenin beta 1
Therapy Area/IndicationsCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSK Biopharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSK Biopharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsCoronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A